Home
Resources
Diseases
COVID-19
Hepatitis B
Human papillomavirus (HPV)
Malaria
Measles
Mpox
Pneumococcal disease
RSV (Respiratory syncytial virus)
Compendium
Hexavalent vaccines
HPV vaccines
Malaria vaccines
PCV vaccines
RSV vaccines
Training
Vaccine Portfolio Optimization and Prioritization (VPOP)
Evaluation
The Tool
The Tutorial
The Dashboard
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Type of publications
Guidelines (40)
NITAG documentation (1641)
Reports (63)
SAGE documentation (226)
Scientific publications (122)
Systematic reviews (SYSVAC) (3100)
Regions
Africa (297)
Americas (794)
Eastern Mediterranean (58)
Europe (744)
Global (1)
South-East Asia (82)
Western Pacific (216)
Diseases
Chikungunya (13)
Cholera (35)
COVID-19 (1589)
Cytomegalovirus (1)
Dengue (43)
Diphtheria (90)
Ebola (19)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (71)
Hepatitis A (69)
Hepatitis B (171)
Hepatitis C (5)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (77)
HIV / AIDS (10)
Human papillomavirus (HPV) (537)
Influenza (629)
Japanese encephalitis (34)
Lyme disease, Borreliosis (2)
Malaria (33)
Measles (144)
Meningococcal disease (155)
Moraxella catarrhalis (1)
Mpox (58)
Mumps (50)
Pertussis (120)
Pneumococcal disease (305)
Poliomyelitis (94)
Q fever (1)
Rabies (33)
Rotavirus (121)
RSV (Respiratory syncytial virus) (69)
Rubella (69)
Salmonella (3)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (71)
Tick-borne encephalitis (14)
Tuberculosis (83)
Typhoid (32)
Varicella (77)
Yellow fever (44)
Zika (1)
Show more
5192 results found
2008
CCNI of Honduras - Meeting minutes No 1/2008
2008
CCNI of Honduras - Meeting minutes No 2/2008
2008
∙
ACIP
Decision Not to Recommend Routine Vaccination of All Children Aged 2--10 Years with Quadrivalent Meningococcal Conjugate Vaccine (MCV4)
2008
EMRO: Improving evidence-based decision making in immunization programmes - Regional Action Plan 2008-2010
2008
∙
Andrew Oxman, Gunn Vist, Pablo Alonso-Coello, Yngve Falck-Ytter, Gordon Guyatt, Regina Kunz, Holger Schünemann
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
2008
∙
Andrew Oxman, Gunn Vist, Yngve Falck-Ytter, Gordon Guyatt, Regina Kunz, Alessandro Liberati, Holger Schünemann
GRADE: going from evidence to recommendations
2008
∙
Andrew Oxman, Gunn Vist, Jan Brozek, Paul Glasziou, John Williams, Jonathan Craig, Victor M Montori, Patrick Bossuyt, Gordon Guyatt, Regina Kunz, Roman Jaeschke, Holger Schünemann
GRADE: grading quality of evidence and strength of recommendations for diagnostic tests and strategies
2008
∙
Andrew Oxman, Gunn Vist, Gordon Guyatt, Regina Kunz, Roman Jaeschke, Mark Helfand, Alessandro Liberati, Holger Schünemann
GRADE: Incorporating considerations of resources use into grading recommendations
2008
∙
Andrew Oxman, Gunn Vist, Yngve Falck-Ytter, Gordon Guyatt, Regina Kunz, Holger Schünemann
GRADE: what is “quality of evidence” and why is it important to clinicians?
2008
∙
ACIP
Human Rabies Prevention
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register
